Abriel H, Loffing J, Rebhun J F, Pratt J H, Schild L, Horisberger J D, Rotin D, Staub O
Institute of Pharmacology and Toxicology, University of Lausanne, CH-1005 Lausanne, Switzerland.
J Clin Invest. 1999 Mar;103(5):667-73. doi: 10.1172/JCI5713.
Liddle's syndrome is an inherited form of hypertension linked to mutations in the epithelial Na+ channel (ENaC). ENaC is composed of three subunits (alpha, beta, gamma), each containing a COOH-terminal PY motif (xPPxY). Mutations causing Liddle's syndrome alter or delete the PY motifs of beta- or gamma-ENaC. We recently demonstrated that the ubiquitin-protein ligase Nedd4 binds these PY motifs and that ENaC is regulated by ubiquitination. Here, we investigate, using the Xenopus oocyte system, whether Nedd4 affects ENaC function. Overexpression of wild-type Nedd4, together with ENaC, inhibited channel activity, whereas a catalytically inactive Nedd4 stimulated it, likely by acting as a competitive antagonist to endogenous Nedd4. These effects were dependant on the PY motifs, because no Nedd4-mediated changes in channel activity were observed in ENaC lacking them. The effect of Nedd4 on ENaC missing only one PY motif (of beta-ENaC), as originally described in patients with Liddle's syndrome, was intermediate. Changes were due entirely to alterations in ENaC numbers at the plasma membrane, as determined by surface binding and immunofluorescence. Our results demonstrate that Nedd4 is a negative regulator of ENaC and suggest that the loss of Nedd4 binding sites in ENaC observed in Liddle's syndrome may explain the increase in channel number at the cell surface, increased Na+ reabsorption by the distal nephron, and hence the hypertension.
利德尔综合征是一种遗传性高血压,与上皮钠离子通道(ENaC)的突变有关。ENaC由三个亚基(α、β、γ)组成,每个亚基都含有一个COOH末端的PY基序(xPPxY)。导致利德尔综合征的突变会改变或删除β-或γ-ENaC的PY基序。我们最近证明泛素蛋白连接酶Nedd4与这些PY基序结合,并且ENaC受泛素化调节。在此,我们使用非洲爪蟾卵母细胞系统研究Nedd4是否影响ENaC功能。野生型Nedd4与ENaC一起过表达会抑制通道活性,而催化失活的Nedd4则会刺激通道活性,这可能是通过作为内源性Nedd4的竞争性拮抗剂发挥作用。这些效应依赖于PY基序,因为在缺乏PY基序的ENaC中未观察到Nedd4介导的通道活性变化。Nedd4对仅缺失一个PY基序(β-ENaC的)的ENaC的影响,正如最初在利德尔综合征患者中所描述的那样,是中等程度的。变化完全是由于质膜上ENaC数量的改变,这是通过表面结合和免疫荧光确定的。我们的结果表明Nedd4是ENaC的负调节因子,并表明在利德尔综合征中观察到的ENaC中Nedd4结合位点的丧失可能解释了细胞表面通道数量的增加、远端肾单位钠重吸收的增加,进而导致高血压。